Anti-PD1/PDL1 Antibody
2 clinical trials · Condition
◉ Watch Anti-PD1/PDL1 Antibody
| Record | Firm | Date |
|---|---|---|
| Locoregional Therapy Combined With Bevacizumab and PD1/L1 Inhibitor in Advanced Hepatocellular Carcinoma (NCT06323382) | Sun Yat-sen University | 2021-01-01 |
Track Anti-PD1/PDL1 Antibody automatically
Every clearance here is in the API, with alerts when new ones post.